The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3′-Azido-3′-deoxythymidine

Rachel A. LaCasse, Kathryn M. Remington, Thomas W. North

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We have developed a host range system to measure the mutation frequency of feline immunodeficiency virus (FIV), the feline homologue of human immunodeficiency virus type 1 (HIV-1). When wild-type FIV was grown in the presence of a known mutagen, 5-bromo-2′-deoxyuridine (BUdR), a dose-dependent increase of host range mutants was detected. Using this system, we have evaluated the effects of antiviral drugs upon the mutation frequency of FIV. Subinhibitory concentrations of 3′-azido-3′-deoxythymidine (AZT), the most common antiviral drug used in AIDS chemotherapy, increased the mutation frequency of FIV in a dose-dependent manner. Two other antivirals, 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxycytidine (ddC), did not show this effect.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume12
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Feline Immunodeficiency Virus
Zidovudine
Mutation Rate
Antiviral Agents
Host Specificity
Bromodeoxyuridine
Zalcitabine
Didanosine
Felidae
Mutagens
HIV-1
Acquired Immunodeficiency Syndrome
Drug Therapy

Keywords

  • Antiviral drugs
  • Feline immunodeficiency virus
  • Lentivirus mutation frequency

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Immunology and Allergy

Cite this

The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3′-Azido-3′-deoxythymidine. / LaCasse, Rachel A.; Remington, Kathryn M.; North, Thomas W.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 12, No. 1, 1996, p. 26-32.

Research output: Contribution to journalArticle

LaCasse, Rachel A. ; Remington, Kathryn M. ; North, Thomas W. / The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3′-Azido-3′-deoxythymidine. In: Journal of Acquired Immune Deficiency Syndromes. 1996 ; Vol. 12, No. 1. pp. 26-32.
@article{36d9c663c59b4a639af3eaf373166820,
title = "The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3′-Azido-3′-deoxythymidine",
abstract = "We have developed a host range system to measure the mutation frequency of feline immunodeficiency virus (FIV), the feline homologue of human immunodeficiency virus type 1 (HIV-1). When wild-type FIV was grown in the presence of a known mutagen, 5-bromo-2′-deoxyuridine (BUdR), a dose-dependent increase of host range mutants was detected. Using this system, we have evaluated the effects of antiviral drugs upon the mutation frequency of FIV. Subinhibitory concentrations of 3′-azido-3′-deoxythymidine (AZT), the most common antiviral drug used in AIDS chemotherapy, increased the mutation frequency of FIV in a dose-dependent manner. Two other antivirals, 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxycytidine (ddC), did not show this effect.",
keywords = "Antiviral drugs, Feline immunodeficiency virus, Lentivirus mutation frequency",
author = "LaCasse, {Rachel A.} and Remington, {Kathryn M.} and North, {Thomas W.}",
year = "1996",
language = "English (US)",
volume = "12",
pages = "26--32",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3′-Azido-3′-deoxythymidine

AU - LaCasse, Rachel A.

AU - Remington, Kathryn M.

AU - North, Thomas W.

PY - 1996

Y1 - 1996

N2 - We have developed a host range system to measure the mutation frequency of feline immunodeficiency virus (FIV), the feline homologue of human immunodeficiency virus type 1 (HIV-1). When wild-type FIV was grown in the presence of a known mutagen, 5-bromo-2′-deoxyuridine (BUdR), a dose-dependent increase of host range mutants was detected. Using this system, we have evaluated the effects of antiviral drugs upon the mutation frequency of FIV. Subinhibitory concentrations of 3′-azido-3′-deoxythymidine (AZT), the most common antiviral drug used in AIDS chemotherapy, increased the mutation frequency of FIV in a dose-dependent manner. Two other antivirals, 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxycytidine (ddC), did not show this effect.

AB - We have developed a host range system to measure the mutation frequency of feline immunodeficiency virus (FIV), the feline homologue of human immunodeficiency virus type 1 (HIV-1). When wild-type FIV was grown in the presence of a known mutagen, 5-bromo-2′-deoxyuridine (BUdR), a dose-dependent increase of host range mutants was detected. Using this system, we have evaluated the effects of antiviral drugs upon the mutation frequency of FIV. Subinhibitory concentrations of 3′-azido-3′-deoxythymidine (AZT), the most common antiviral drug used in AIDS chemotherapy, increased the mutation frequency of FIV in a dose-dependent manner. Two other antivirals, 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxycytidine (ddC), did not show this effect.

KW - Antiviral drugs

KW - Feline immunodeficiency virus

KW - Lentivirus mutation frequency

UR - http://www.scopus.com/inward/record.url?scp=0030007820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030007820&partnerID=8YFLogxK

M3 - Article

C2 - 8624757

AN - SCOPUS:0030007820

VL - 12

SP - 26

EP - 32

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 1

ER -